Novoa-Loyola Jose E. 4
4 · TRIPLE-S MANAGEMENT CORP · Filed Mar 7, 2019
Insider Transaction Report
Form 4
Novoa-Loyola Jose E.
Chief Medical Officer
Transactions
- Award
Class B Common Stock
2019-03-05+4,129→ 18,974 total - Award
Class B Common Stock
2019-03-05+1,456→ 20,430 total - Award
Class B Common Stock
2019-03-05+600→ 21,030 total
Footnotes (3)
- [F1]Shares acquired represent a grant of restricted stock that will vest in equal installments on each of March 5, 2020 and 2021 and March 7, 2022.
- [F2]Shares acquired represent a grant of restricted stock as a one-time Special Retention Award that will vest in equal installments on each of March 5, 2020 and 2021 and March 7, 2022.
- [F3]Shares acquired represent common stock earned pursuant to a grant of Performance Shares on May 10, 2016. The Performance Shares resulting in the issuance of these shares of common stock did not constitute derivative securities. As a result, such Performance Shares were not required to be reported and were not reported on a Form 4 at the time of the award.